Science news articles about 'cetuximab erbitux'

... today at the annual meeting of the International Association for the Study of Lung Cancer. Both cetuximab (Erbitux) and erlotinib (Tarceva) inhibit the epidermal growth factor receptor (EGFR) and the ...

... -small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less ... drug's true effects. "We found that patients who got cetuximab had a 13% lower chance of dying within ...

... drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, ...

... the disease. The investigators focused on the use of the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux) because of these drugs' clinical importance, significant media coverage, and ...

... this should become standard practice. Anti-epidermal growth factor receptor (EGFR) antibodies cetuximab (Erbitux) and panitumumab (Vectibix) are both targeted monoclonal antibody ...

... Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson. Cetuximab (Erbitux) is a monoclonal antibody that binds to and inhibits the epidermal growth factor receptor ( ...